KROS - Keros Therapeutics EPS beats by $0.06 August, 13 2020 07:18 AM Keros Therapeutics Inc. Keros Therapeutics (NASDAQ:KROS): Q2 GAAP EPS of -$0.62 beats by $0.06.cash and cash equivalents of $144.7M.Press ReleaseMore news on: Keros Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,